For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Tusk Therapeutics Ltd.

USPTO Granted Patents = 12

EPO Patents = 9

Forward Citations = 30

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Sergio Quezada (12 out of 13 patents)

Anne Goubier (12 out of 19 patents)

Beatriz Goyenechea Corzo (12 out of 19 patents)

4. Josephine Salimu (12 out of 19 patents)

5. Kevin Moulder (12 out of 19 patents)

6. Pascal Merchiers (12 out of 19 patents)

7. Bianka Prinz (8 out of 58 patents)

8. Mark Brown (8 out of 8 patents)

9. James Geoghegan (8 out of 8 patents)

10. Karl Peggs (1 out of 2 patents)

11. Frederick Arce Vargas (1 out of 1 patent)

12. Isabelle Solomon (1 out of 1 patent)

13. Joseph Mabbitt (0 patent)

14. Stephanie Hopley (0 patent)

12 patents: Sort by Forward Citations

1. 11919960 - Anti-CD25 antibody agents (2024-03-05),

2. 11879014 - Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody (2024-01-23),

3. 11873341 - Anti-CD25 for tumour specific cell depletion (2024-01-16),

4. 11851494 - Anti-CD25 for tumour specific cell depletion (2023-12-26),

5. 11814434 - Anti-CD25 for tumour specific cell depletion (2023-11-14),

6. 11802161 - Anti-CD25 for tumour specific cell depletion (2023-10-31),

7. 11802160 - Anti-CD25 antibody agents (2023-10-31),

8. 11787866 - Anti-CD25 antibody agents (2023-10-17),

9. 11697688 - Anti-CD25 for tumour specific cell depletion (2023-07-11),

10. 10752691 - Anti-CD25 antibody agents (2020-08-25),

11. 10745485 - Anti-CD25 antibody agents (2020-08-18),

12. 10738125 - Anti-CD25 antibody agents (2020-08-11),

Tusk Therapeutics Ltd. is a biotechnology company focused on developing novel cancer therapies. With a strong emphasis on immunotherapy, Tusk Therapeutics is dedicated to advancing the field of oncology through cutting-edge research and innovation. The company's pipeline includes promising drug candidates aimed at targeting various types of cancer, with the ultimate goal of improving patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

12 Patents

#246 in London

#1,438 in United Kingdom

#46,736 in the World

London, United Kingdom

Tusk Therapeutics Ltd.

Forward Citations = 30

12 inventors:

Sergio Quezada (12 out of 13 patents)

Anne Goubier (12 out of 19 patents)

Beatriz Goyenechea Corzo (12 out of 19 patents)

4. Josephine Salimu (12 out of 19 patents)

5. Kevin Moulder (12 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…